| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 192.123 | 777.901 | 700.861 | 820.524 |
| Total Income - EUR | - | - | - | - | - | - | 192.123 | 782.511 | 701.657 | 821.523 |
| Total Expenses - EUR | - | - | - | - | - | - | 57.634 | 387.388 | 508.553 | 644.834 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 134.489 | 395.123 | 193.104 | 176.689 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 132.567 | 387.273 | 163.357 | 148.925 |
| Employees | - | - | - | - | - | - | 7 | 16 | 16 | 12 |
Check the financial reports for the company - Oculist S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 115.260 | 175.614 | 886.726 | 800.971 |
| Current Assets | - | - | - | - | - | - | 59.697 | 134.598 | 34.071 | 57.862 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 320 | 4.256 | 17.633 | 11.387 |
| Cash | - | - | - | - | - | - | 59.377 | 130.342 | 16.438 | 46.475 |
| Shareholders Funds | - | - | - | - | - | - | 132.608 | 83.147 | 246.252 | 148.965 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 42.350 | 227.065 | 674.545 | 709.868 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oculist S.r.l.